Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep;21(9):656-61.
doi: 10.1007/s11655-015-2306-z. Epub 2015 Oct 3.

Shen (Kidney)-tonifying principle for primary osteoporosis: to treat both the disease and the Chinese medicine syndrome

Affiliations
Review

Shen (Kidney)-tonifying principle for primary osteoporosis: to treat both the disease and the Chinese medicine syndrome

Bing Shu et al. Chin J Integr Med. 2015 Sep.

Abstract

Primary osteoporosis (POP) is one of the most common diseases in the elderly people resulting in high risk of fracture and poor quality of life. In addition to the pathological changes in bone mass, most of the POP patients also suffer from Chinese medicine (CM) syndromes of Shen (Kidney) essence deficiency. Shen essences are highly related to bone. Shen essence deficiency plays an important part in the development of POP and a better diagnosis of POP could be made by combining CM syndromes with Western medicine risk factors. Treatments of POP should aim at both increasing the bone mass and relieving the syndromes of Shen essence deficiency. Clinical study confirmed that treating POP patients with Shen-tonifying herbs could increase the bone mass and relieve the CM syndromes of POP patients. Basic researches clarified the mechanism by which Shen-tonifying herbs increased bone mass in animal models. The mechanisms by which Shentonifying herbs relieve the CM syndromes are still in investigation.

Keywords: Chinese medicine; Shen (Kidney) essence deficiency; Shen (Kidney)-tonifying herbs; primary osteoporosis; syndrome.

PubMed Disclaimer

References

    1. J Biol Chem. 2003 Jul 18;278(29):26970-5 - PubMed
    1. Front Biosci (Elite Ed). 2012 Jan 01;4:1224-36 - PubMed
    1. Int J Biol Sci. 2012;8(2):272-88 - PubMed
    1. Calcif Tissue Int. 2013 Aug;93(2):121-32 - PubMed
    1. Dev Cell. 2005 May;8(5):751-64 - PubMed

Publication types

Substances

LinkOut - more resources